record initialized not assigned to examiner
on 27 Oct 2023
Last Applicant/ Owned by
200 Boston Avenue, Suite 1000
Medford
US
02155
Serial Number
98236427 filed on 23rd Oct 2023
Registration Number
N/A
Correspondent Address
RACHELLE A. UBOW, ESQ.MORGAN, LEWIS & BOCKIUS LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; design and engineering in the field of producing RNA and cell-free processing; research Read More
Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; design and engineering in the field of producing RNA and cell-free processing; research and development services in the field of producing, manufacturing, and processing of RNA and RNA formulations for scientific, research, medical, pharmaceutical, veterinary, agricultural food, chemical and energy production, industrial and manufacturing use; research and development services in the field of formulations for the delivery of RNA for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use
Chemical reagents and RNA sequences being chemical reagents used to repel or destroy insects, pests, parasites, and vermin; Agricultural products, namely, insecticides, pesticides, fungicides; preparations for destroying vermin; Chemical reagents and RNA sequences being chemical reagents used for improving bee health; Pharmaceutical products and veterinary products for human and animal health in the nature of vaccines and RNA therapeutics for the treatment of parasitic infection or infestations, infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely, mRNA therapeutics and siRNA therapeutics for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, parasitic infection or infestation, and cancer
Chemical reagents and RNA sequences being chemical reagents for agricultural purposes, and not medical or veterinary purposes, namely, for crop protection and to improve plant health and plant yield; chemical treatments applied to seeds, plants and crops to improve plant health and yield
No 98236427
No Service Mark
No 128041-0006
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
27th Oct 2023 | NEW APPLICATION OICE SUPPLIE ATA ENTERE |
26th Oct 2023 | NEW APPLICATION ENTERE |